Form D · Investing
PCG CytoAgents LLC
Pittsburgh, PA · CIK 0001976346
Offering snapshot reported May 10, 2023 · SEC filing
- Reported sold
- $3.33M Offering amount: $3.33M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 28, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 10, 2023 | Initial | $3,333,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-481318
Source: Form D, filed May 10, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeremy T. Kaylor | Executive |
| Penn Cove Group Capital, Llc | Director, Promoter |
| Brian P. Shanahan | Executive, Promoter |
Issuer details
Industry: Investing (See others in industry)
Address:
11 Stanwix Street Suite 1202
Pittsburgh, PA, 15222
Pittsburgh, PA, 15222